GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Helix BioPharma Corp (TSX:HBP) » Definitions » Price-to-Tangible-Book

Helix BioPharma (TSX:HBP) Price-to-Tangible-Book : (As of May. 26, 2024)


View and export this data going back to 1996. Start your Free Trial

What is Helix BioPharma Price-to-Tangible-Book?

As of today (2024-05-26), Helix BioPharma's share price is C$0.205. Helix BioPharma's Tangible Book per Share of Jan. 2024 for the quarter that ended in Jan. 2024 was C$-0.00. Hence, Helix BioPharma's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Helix BioPharma's Price-to-Tangible-Book or its related term are showing as below:

During the past 13 years, Helix BioPharma's highest Price to Tangible Book Ratio was 1250.00. The lowest was 16.00. And the median was 42.55.

TSX:HBP's Price-to-Tangible-Book is not ranked *
in the Biotechnology industry.
Industry Median: 2.79
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Helix BioPharma's share price is C$0.205. Helix BioPharma's Book Value per Sharefor the quarter that ended in Jan. 2024 was C$-0.00. Hence, Helix BioPharma's P/B Ratio of today is .


Helix BioPharma Price-to-Tangible-Book Historical Data

The historical data trend for Helix BioPharma's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Helix BioPharma Price-to-Tangible-Book Chart

Helix BioPharma Annual Data
Trend Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 30.00 - 95.00 -

Helix BioPharma Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.00 41.00 - 73.33 -

Competitive Comparison of Helix BioPharma's Price-to-Tangible-Book

For the Biotechnology subindustry, Helix BioPharma's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Helix BioPharma's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Helix BioPharma's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Helix BioPharma's Price-to-Tangible-Book falls into.



Helix BioPharma Price-to-Tangible-Book Calculation

Helix BioPharma's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Jan. 2024 )
=0.205/-0.001
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Helix BioPharma Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Helix BioPharma's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Helix BioPharma (TSX:HBP) Business Description

Traded in Other Exchanges
Address
401 Bay Street, Suite 2704, Toronto, ON, CAN, M5H 2Y
Helix BioPharma Corp is a clinical-stage biopharmaceutical company. It is focused on cancer drug development. The company develops therapies in the field of immuno-oncology based on its proprietary technology mainly in the areas of cancer prevention and treatment. Its pipeline candidates are Tumor Defence Breaker L-DOS47, and, V-DOS47 among others.